

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.85871951 |
| 2 | glutamate receptor signaling pathway (GO:0007215) | 5.63570688 |
| 3 | vocalization behavior (GO:0071625) | 5.32454890 |
| 4 | protein localization to synapse (GO:0035418) | 5.04439163 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.93878836 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86560836 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.85661923 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.73042220 |
| 9 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.68826010 |
| 10 | synaptic transmission, glutamatergic (GO:0035249) | 4.56537326 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.55664548 |
| 12 | neuron-neuron synaptic transmission (GO:0007270) | 4.49437812 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.47568064 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.47082286 |
| 15 | neuron recognition (GO:0008038) | 4.42938006 |
| 16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40050861 |
| 17 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.33170786 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.25106360 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.23821588 |
| 20 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.20418744 |
| 21 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.16263697 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.14740811 |
| 23 | exploration behavior (GO:0035640) | 4.14680904 |
| 24 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.13631184 |
| 25 | positive regulation of synapse maturation (GO:0090129) | 4.13416503 |
| 26 | behavioral fear response (GO:0001662) | 4.03375058 |
| 27 | behavioral defense response (GO:0002209) | 4.03375058 |
| 28 | axonal fasciculation (GO:0007413) | 3.98745348 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.97430535 |
| 30 | response to histamine (GO:0034776) | 3.97398406 |
| 31 | long-term synaptic potentiation (GO:0060291) | 3.95654112 |
| 32 | regulation of postsynaptic membrane potential (GO:0060078) | 3.92034269 |
| 33 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.89660031 |
| 34 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.89129430 |
| 35 | L-amino acid import (GO:0043092) | 3.85617450 |
| 36 | long-term memory (GO:0007616) | 3.81591246 |
| 37 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.81289721 |
| 38 | regulation of synaptic plasticity (GO:0048167) | 3.80308344 |
| 39 | glutamate secretion (GO:0014047) | 3.79686913 |
| 40 | fear response (GO:0042596) | 3.79164651 |
| 41 | long term synaptic depression (GO:0060292) | 3.75012302 |
| 42 | sodium ion export (GO:0071436) | 3.74691122 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.69109653 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.67511782 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.65338315 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.62868518 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.62803695 |
| 48 | dendritic spine organization (GO:0097061) | 3.61674944 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 3.61515726 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61028643 |
| 51 | innervation (GO:0060384) | 3.59888913 |
| 52 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.56733689 |
| 53 | regulation of dendritic spine development (GO:0060998) | 3.56584667 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.50813748 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50029367 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.47748029 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.47502383 |
| 58 | synaptic vesicle maturation (GO:0016188) | 3.46805501 |
| 59 | regulation of synapse structural plasticity (GO:0051823) | 3.46566987 |
| 60 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45568331 |
| 61 | regulation of glutamate secretion (GO:0014048) | 3.44725984 |
| 62 | regulation of vesicle fusion (GO:0031338) | 3.42679056 |
| 63 | behavioral response to cocaine (GO:0048148) | 3.42093778 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 3.39062039 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.37189537 |
| 66 | regulation of Rac protein signal transduction (GO:0035020) | 3.35866220 |
| 67 | learning (GO:0007612) | 3.34761815 |
| 68 | cochlea development (GO:0090102) | 3.34391485 |
| 69 | synaptic transmission, dopaminergic (GO:0001963) | 3.32684542 |
| 70 | positive regulation of membrane potential (GO:0045838) | 3.32359374 |
| 71 | regulation of female receptivity (GO:0045924) | 3.29780642 |
| 72 | chemosensory behavior (GO:0007635) | 3.27351605 |
| 73 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.23750657 |
| 74 | membrane depolarization (GO:0051899) | 3.23192842 |
| 75 | glycosphingolipid biosynthetic process (GO:0006688) | 3.22973474 |
| 76 | amino acid import (GO:0043090) | 3.21800493 |
| 77 | inner ear receptor cell development (GO:0060119) | 3.21677878 |
| 78 | postsynaptic membrane organization (GO:0001941) | 3.21256020 |
| 79 | neurotransmitter secretion (GO:0007269) | 3.20458565 |
| 80 | presynaptic membrane organization (GO:0097090) | 3.19471749 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 3.19409757 |
| 82 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.18793104 |
| 83 | response to amphetamine (GO:0001975) | 3.18481591 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18138482 |
| 85 | regulation of neuron projection regeneration (GO:0070570) | 3.17943037 |
| 86 | regulation of axon regeneration (GO:0048679) | 3.17943037 |
| 87 | regulation of synapse maturation (GO:0090128) | 3.16595222 |
| 88 | startle response (GO:0001964) | 3.15184492 |
| 89 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.14370298 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 3.12323813 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.11885271 |
| 92 | nerve growth factor signaling pathway (GO:0038180) | 3.11156809 |
| 93 | striatum development (GO:0021756) | 3.10760317 |
| 94 | female mating behavior (GO:0060180) | 3.10154346 |
| 95 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.07702555 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07540612 |
| 97 | membrane depolarization during action potential (GO:0086010) | 3.06869176 |
| 98 | ephrin receptor signaling pathway (GO:0048013) | 3.06693647 |
| 99 | vesicle transport along microtubule (GO:0047496) | 3.06376732 |
| 100 | serotonin metabolic process (GO:0042428) | 3.05064747 |
| 101 | cerebellar granule cell differentiation (GO:0021707) | 3.04630494 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.01538222 |
| 103 | neurotransmitter transport (GO:0006836) | 2.98321061 |
| 104 | neuron remodeling (GO:0016322) | 2.97494419 |
| 105 | positive regulation of vesicle fusion (GO:0031340) | 2.94137452 |
| 106 | negative regulation of amino acid transport (GO:0051956) | 2.93193934 |
| 107 | synaptic transmission (GO:0007268) | 2.88952198 |
| 108 | regulation of synaptic transmission (GO:0050804) | 2.88868619 |
| 109 | detection of calcium ion (GO:0005513) | 2.88531545 |
| 110 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.87790360 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86687107 |
| 112 | negative regulation of cell killing (GO:0031342) | 2.86687107 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.82732845 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.80031930 |
| 115 | cellular response to ethanol (GO:0071361) | 2.75653702 |
| 116 | potassium ion import (GO:0010107) | 2.75007575 |
| 117 | regulation of neurotransmitter transport (GO:0051588) | 2.73838323 |
| 118 | neuromuscular process controlling balance (GO:0050885) | 2.72927738 |
| 119 | proline transport (GO:0015824) | 2.72131004 |
| 120 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71948031 |
| 121 | membrane assembly (GO:0071709) | 2.68426384 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.67476023 |
| 123 | lipid translocation (GO:0034204) | 2.61365237 |
| 124 | phospholipid translocation (GO:0045332) | 2.61365237 |
| 125 | clathrin coat assembly (GO:0048268) | 2.58677028 |
| 126 | neuromuscular synaptic transmission (GO:0007274) | 2.58195639 |
| 127 | negative regulation of dendrite development (GO:2000171) | 2.49871255 |
| 128 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.49032462 |
| 129 | regulation of cell communication by electrical coupling (GO:0010649) | 2.48323887 |
| 130 | vesicle docking (GO:0048278) | 2.46725621 |
| 131 | neutrophil mediated immunity (GO:0002446) | 2.44284089 |
| 132 | regulation of neurotransmitter levels (GO:0001505) | 2.43712621 |
| 133 | synaptic vesicle transport (GO:0048489) | 2.41775817 |
| 134 | establishment of synaptic vesicle localization (GO:0097480) | 2.41775817 |
| 135 | positive regulation of heat generation (GO:0031652) | 2.41271560 |
| 136 | dendrite morphogenesis (GO:0048813) | 2.40551666 |
| 137 | neuromuscular process (GO:0050905) | 2.39944190 |
| 138 | potassium ion homeostasis (GO:0055075) | 2.39570387 |
| 139 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.38345201 |
| 140 | regulation of fever generation (GO:0031620) | 2.37927135 |
| 141 | positive regulation of macrophage cytokine production (GO:0060907) | 2.37874279 |
| 142 | protein localization to endosome (GO:0036010) | 2.37357580 |
| 143 | acidic amino acid transport (GO:0015800) | 2.37159903 |
| 144 | regulation of exocytosis (GO:0017157) | 2.36323255 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 2.36270229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.18929179 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.21297954 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10147050 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09649633 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00944424 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.75378650 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56537066 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56537066 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51231901 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49511075 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47498433 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45592747 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39026115 |
| 14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.38381496 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38263572 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32273818 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29449057 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.22324879 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.17323355 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13574634 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.13336010 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12160493 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07881867 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01746686 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99785931 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99002963 |
| 27 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88044161 |
| 28 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.87755050 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86297231 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84022991 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83048821 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81425205 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81325052 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76201157 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75634997 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72686045 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68477502 |
| 38 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68050403 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64724869 |
| 40 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.63388066 |
| 41 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62399154 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61974489 |
| 43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60040473 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59966245 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57360172 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57360172 |
| 47 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54744108 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52767968 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47923998 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47092141 |
| 51 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45859889 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44989500 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44614232 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44162957 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43440519 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43163562 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42549109 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41054788 |
| 59 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40355909 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39270773 |
| 61 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38859656 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37648656 |
| 63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.37635303 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36976614 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36106589 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35880103 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34080010 |
| 68 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33954894 |
| 69 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32999408 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32399089 |
| 71 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31725861 |
| 72 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31658404 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29414816 |
| 74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28573567 |
| 75 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.28559471 |
| 76 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28218773 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27849690 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27374951 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27213988 |
| 80 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.26375723 |
| 81 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26343755 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25074345 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24376088 |
| 84 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24006984 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23235190 |
| 86 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23065118 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22032899 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21243757 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19459590 |
| 90 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18950522 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16750197 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16104165 |
| 93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15632438 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15578753 |
| 95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14978628 |
| 96 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14761438 |
| 97 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13685500 |
| 98 | JUN_21703547_ChIP-Seq_K562_Human | 1.13406685 |
| 99 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13298094 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12549403 |
| 101 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11406998 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10730466 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09720874 |
| 104 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09422376 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09310275 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08366265 |
| 107 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07133732 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06646261 |
| 109 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06622835 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06376225 |
| 111 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06331248 |
| 112 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06154534 |
| 113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04485001 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03435209 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02695059 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02525195 |
| 117 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01885481 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01587276 |
| 119 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01587040 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01206499 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99826450 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99826450 |
| 123 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97565290 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96631057 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96084734 |
| 126 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95717763 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95015780 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94271479 |
| 129 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.93589757 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92298249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.58209482 |
| 2 | MP0003880_abnormal_central_pattern | 6.25409594 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.25253482 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.21686133 |
| 5 | MP0004270_analgesia | 3.86268877 |
| 6 | MP0009745_abnormal_behavioral_response | 3.61998331 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.59737468 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.14241812 |
| 9 | MP0002064_seizures | 3.00426080 |
| 10 | MP0002822_catalepsy | 2.95352813 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.93897052 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.87818745 |
| 13 | MP0002736_abnormal_nociception_after | 2.86690176 |
| 14 | MP0002272_abnormal_nervous_system | 2.60882584 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.40543964 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.39795431 |
| 17 | MP0001486_abnormal_startle_reflex | 2.37123091 |
| 18 | MP0009046_muscle_twitch | 2.34726552 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.20832266 |
| 20 | MP0003329_amyloid_beta_deposits | 2.14090423 |
| 21 | MP0001188_hyperpigmentation | 2.10414711 |
| 22 | MP0002067_abnormal_sensory_capabilities | 1.91224640 |
| 23 | MP0000778_abnormal_nervous_system | 1.84280646 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.84124951 |
| 25 | MP0003690_abnormal_glial_cell | 1.81011711 |
| 26 | MP0002184_abnormal_innervation | 1.80437472 |
| 27 | MP0001529_abnormal_vocalization | 1.80057584 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.78507315 |
| 29 | MP0003123_paternal_imprinting | 1.76774166 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.73631836 |
| 31 | MP0001970_abnormal_pain_threshold | 1.73507018 |
| 32 | MP0003303_peritoneal_inflammation | 1.71067303 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.69751334 |
| 34 | MP0003787_abnormal_imprinting | 1.68182783 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.65220012 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.60597059 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.57955938 |
| 38 | MP0008057_abnormal_DNA_replication | 1.56988578 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.55384350 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.55014453 |
| 41 | MP0004924_abnormal_behavior | 1.54058310 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.54058310 |
| 43 | MP0003879_abnormal_hair_cell | 1.53051238 |
| 44 | MP0001299_abnormal_eye_distance/ | 1.50885824 |
| 45 | MP0005409_darkened_coat_color | 1.49889104 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.49272083 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.45862857 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.38923072 |
| 49 | MP0004858_abnormal_nervous_system | 1.38912182 |
| 50 | MP0006054_spinal_hemorrhage | 1.38788848 |
| 51 | MP0001984_abnormal_olfaction | 1.35849882 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.34744849 |
| 53 | MP0004510_myositis | 1.34522898 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.33839755 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.32274315 |
| 56 | MP0003890_abnormal_embryonic-extraembry | 1.31868893 |
| 57 | MP0008569_lethality_at_weaning | 1.30532491 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.28867059 |
| 59 | MP0003091_abnormal_cell_migration | 1.28531974 |
| 60 | MP0000955_abnormal_spinal_cord | 1.28094253 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.28063566 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.26147410 |
| 63 | MP0003121_genomic_imprinting | 1.24053862 |
| 64 | MP0006292_abnormal_olfactory_placode | 1.22591193 |
| 65 | MP0003950_abnormal_plasma_membrane | 1.22308092 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.21597207 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.20993520 |
| 68 | MP0005248_abnormal_Harderian_gland | 1.20934133 |
| 69 | MP0003633_abnormal_nervous_system | 1.16477329 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.14048302 |
| 71 | MP0001905_abnormal_dopamine_level | 1.13681685 |
| 72 | MP0004484_altered_response_of | 1.12938940 |
| 73 | MP0000604_amyloidosis | 1.11916148 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.08142897 |
| 75 | MP0003828_pulmonary_edema | 1.06397647 |
| 76 | MP0000383_abnormal_hair_follicle | 1.06364415 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.00142679 |
| 78 | MP0004885_abnormal_endolymph | 1.00119069 |
| 79 | MP0003631_nervous_system_phenotype | 0.97599166 |
| 80 | MP0005166_decreased_susceptibility_to | 0.97393325 |
| 81 | MP0002152_abnormal_brain_morphology | 0.97143791 |
| 82 | MP0003045_fibrosis | 0.96239380 |
| 83 | MP0000751_myopathy | 0.95628265 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.95068978 |
| 85 | MP0005623_abnormal_meninges_morphology | 0.92975038 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.90796884 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.90112465 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.89193088 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.88839998 |
| 90 | MP0002229_neurodegeneration | 0.88409549 |
| 91 | MP0008874_decreased_physiological_sensi | 0.87782850 |
| 92 | MP0004142_abnormal_muscle_tone | 0.87201259 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.86305048 |
| 94 | MP0004085_abnormal_heartbeat | 0.86282051 |
| 95 | MP0005535_abnormal_body_temperature | 0.85764023 |
| 96 | MP0002009_preneoplasia | 0.85262794 |
| 97 | MP0004742_abnormal_vestibular_system | 0.84766323 |
| 98 | MP0005388_respiratory_system_phenotype | 0.82387973 |
| 99 | MP0002133_abnormal_respiratory_system | 0.82387973 |
| 100 | MP0000427_abnormal_hair_cycle | 0.79132162 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.78331944 |
| 102 | MP0008872_abnormal_physiological_respon | 0.78240375 |
| 103 | MP0000733_abnormal_muscle_development | 0.77698051 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.77271143 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.74985383 |
| 106 | MP0003075_altered_response_to | 0.74741400 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.74717276 |
| 108 | MP0008004_abnormal_stomach_pH | 0.74649476 |
| 109 | MP0001664_abnormal_digestion | 0.72225564 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.70101521 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.70022268 |
| 112 | MP0005310_abnormal_salivary_gland | 0.69938293 |
| 113 | MP0009379_abnormal_foot_pigmentation | 0.69888075 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.69825619 |
| 115 | MP0001177_atelectasis | 0.68320841 |
| 116 | MP0005499_abnormal_olfactory_system | 0.66602303 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.66602303 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66223480 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.66056012 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.65674636 |
| 121 | MP0002090_abnormal_vision | 0.65541544 |
| 122 | MP0005164_abnormal_response_to | 0.63561110 |
| 123 | MP0000026_abnormal_inner_ear | 0.61809577 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.61675009 |
| 125 | MP0003632_abnormal_nervous_system | 0.61385990 |
| 126 | MP0003122_maternal_imprinting | 0.61184009 |
| 127 | MP0004233_abnormal_muscle_weight | 0.57964064 |
| 128 | MP0005187_abnormal_penis_morphology | 0.57885843 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.57689330 |
| 130 | MP0003634_abnormal_glial_cell | 0.57614391 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.54858736 |
| 132 | MP0004883_abnormal_blood_vessel | 0.54443986 |
| 133 | MP0003283_abnormal_digestive_organ | 0.53230329 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.52417588 |
| 135 | MP0000920_abnormal_myelination | 0.51517709 |
| 136 | MP0006072_abnormal_retinal_apoptosis | 0.51284086 |
| 137 | MP0005171_absent_coat_pigmentation | 0.48957401 |
| 138 | MP0003137_abnormal_impulse_conducting | 0.46719426 |
| 139 | MP0003861_abnormal_nervous_system | 0.45220586 |
| 140 | MP0001943_abnormal_respiration | 0.44623113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.83739008 |
| 2 | Focal seizures (HP:0007359) | 6.01503488 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.44521951 |
| 4 | Myokymia (HP:0002411) | 5.36977906 |
| 5 | Atonic seizures (HP:0010819) | 5.30515874 |
| 6 | Hyperventilation (HP:0002883) | 5.13810036 |
| 7 | Visual hallucinations (HP:0002367) | 5.06790903 |
| 8 | Absence seizures (HP:0002121) | 4.99866064 |
| 9 | Febrile seizures (HP:0002373) | 4.99458130 |
| 10 | Dialeptic seizures (HP:0011146) | 4.55571585 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.17652212 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.05249420 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.90252874 |
| 14 | Amblyopia (HP:0000646) | 3.90016014 |
| 15 | Broad-based gait (HP:0002136) | 3.83422355 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.66743845 |
| 17 | Drooling (HP:0002307) | 3.55252282 |
| 18 | Excessive salivation (HP:0003781) | 3.55252282 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.54090397 |
| 20 | Papilledema (HP:0001085) | 3.26527616 |
| 21 | Dysmetria (HP:0001310) | 3.19593700 |
| 22 | Absent speech (HP:0001344) | 3.18526733 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.10274596 |
| 24 | Papillary thyroid carcinoma (HP:0002895) | 3.06049733 |
| 25 | Hydroureter (HP:0000072) | 3.05426782 |
| 26 | Abnormality of binocular vision (HP:0011514) | 3.04334837 |
| 27 | Diplopia (HP:0000651) | 3.04334837 |
| 28 | Truncal ataxia (HP:0002078) | 3.03265072 |
| 29 | Testicular atrophy (HP:0000029) | 3.01393124 |
| 30 | Dysdiadochokinesis (HP:0002075) | 3.00952136 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 3.00939427 |
| 32 | Anxiety (HP:0000739) | 2.99058045 |
| 33 | Poor eye contact (HP:0000817) | 2.98532635 |
| 34 | Hemiparesis (HP:0001269) | 2.94542260 |
| 35 | Action tremor (HP:0002345) | 2.93134071 |
| 36 | Akinesia (HP:0002304) | 2.90030430 |
| 37 | Cystic hygroma (HP:0000476) | 2.75663267 |
| 38 | Impaired smooth pursuit (HP:0007772) | 2.74085866 |
| 39 | Lower limb muscle weakness (HP:0007340) | 2.73705833 |
| 40 | Thickened helices (HP:0000391) | 2.73506870 |
| 41 | Spastic gait (HP:0002064) | 2.71605061 |
| 42 | Impaired social interactions (HP:0000735) | 2.70483748 |
| 43 | Abnormal social behavior (HP:0012433) | 2.70483748 |
| 44 | Protruding tongue (HP:0010808) | 2.62397906 |
| 45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.60536129 |
| 46 | Depression (HP:0000716) | 2.58795002 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52845905 |
| 48 | Scanning speech (HP:0002168) | 2.51539908 |
| 49 | Genetic anticipation (HP:0003743) | 2.49723145 |
| 50 | Abnormality of salivation (HP:0100755) | 2.49561389 |
| 51 | Subacute progressive viral hepatitis (HP:0006572) | 2.48469796 |
| 52 | Apathy (HP:0000741) | 2.47403023 |
| 53 | Absent frontal sinuses (HP:0002688) | 2.46078742 |
| 54 | Stereotypic behavior (HP:0000733) | 2.41801044 |
| 55 | Popliteal pterygium (HP:0009756) | 2.40539440 |
| 56 | Insidious onset (HP:0003587) | 2.39903749 |
| 57 | Termporal pattern (HP:0011008) | 2.39903749 |
| 58 | Large earlobe (HP:0009748) | 2.39814885 |
| 59 | Disinhibition (HP:0000734) | 2.38762348 |
| 60 | Decreased circulating renin level (HP:0003351) | 2.36354439 |
| 61 | Ankle clonus (HP:0011448) | 2.33123014 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.32311390 |
| 63 | Delusions (HP:0000746) | 2.31064271 |
| 64 | Retinal dysplasia (HP:0007973) | 2.26952985 |
| 65 | Status epilepticus (HP:0002133) | 2.24841957 |
| 66 | Diminished motivation (HP:0000745) | 2.24604371 |
| 67 | Progressive inability to walk (HP:0002505) | 2.24246996 |
| 68 | Inability to walk (HP:0002540) | 2.23610829 |
| 69 | Widely spaced teeth (HP:0000687) | 2.21633523 |
| 70 | Fair hair (HP:0002286) | 2.21037594 |
| 71 | Torticollis (HP:0000473) | 2.20398953 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.19991436 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17948905 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17948905 |
| 75 | Abnormality of the lower motor neuron (HP:0002366) | 2.17702187 |
| 76 | Type II lissencephaly (HP:0007260) | 2.15416336 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.14578492 |
| 78 | Volvulus (HP:0002580) | 2.14547646 |
| 79 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.12623119 |
| 80 | Tetraplegia (HP:0002445) | 2.12577049 |
| 81 | Mutism (HP:0002300) | 2.11768637 |
| 82 | Psychosis (HP:0000709) | 2.10246808 |
| 83 | Nuclear cataract (HP:0100018) | 2.10200233 |
| 84 | Oligodactyly (hands) (HP:0001180) | 2.08660216 |
| 85 | Bradykinesia (HP:0002067) | 2.07474721 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.07378407 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.06731246 |
| 88 | Overgrowth (HP:0001548) | 2.06157238 |
| 89 | Postural instability (HP:0002172) | 2.05557820 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.05099908 |
| 91 | Inappropriate behavior (HP:0000719) | 2.04503433 |
| 92 | Abnormal eating behavior (HP:0100738) | 2.03657611 |
| 93 | Agnosia (HP:0010524) | 2.03131776 |
| 94 | Global brain atrophy (HP:0002283) | 2.02658032 |
| 95 | Generalized hypopigmentation of hair (HP:0011358) | 2.01675374 |
| 96 | Choroideremia (HP:0001139) | 2.00878849 |
| 97 | Deep palmar crease (HP:0006191) | 2.00408871 |
| 98 | Blue irides (HP:0000635) | 1.99432315 |
| 99 | Lower limb asymmetry (HP:0100559) | 1.99411162 |
| 100 | Clonus (HP:0002169) | 1.99094441 |
| 101 | Dysmetric saccades (HP:0000641) | 1.98844497 |
| 102 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.96501324 |
| 103 | Limb dystonia (HP:0002451) | 1.94066652 |
| 104 | Fetal akinesia sequence (HP:0001989) | 1.93541069 |
| 105 | Exotropia (HP:0000577) | 1.93270682 |
| 106 | Arterial tortuosity (HP:0005116) | 1.92748109 |
| 107 | Curly hair (HP:0002212) | 1.90954309 |
| 108 | Cubitus valgus (HP:0002967) | 1.90862244 |
| 109 | Heterochromia iridis (HP:0001100) | 1.89886360 |
| 110 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89591276 |
| 111 | Syncope (HP:0001279) | 1.88735411 |
| 112 | Rapidly progressive (HP:0003678) | 1.87534459 |
| 113 | Deeply set eye (HP:0000490) | 1.87387932 |
| 114 | Urinary urgency (HP:0000012) | 1.86882596 |
| 115 | Amyotrophic lateral sclerosis (HP:0007354) | 1.85754944 |
| 116 | Autism (HP:0000717) | 1.85381505 |
| 117 | Congenital malformation of the right heart (HP:0011723) | 1.83335660 |
| 118 | Double outlet right ventricle (HP:0001719) | 1.83335660 |
| 119 | Aqueductal stenosis (HP:0002410) | 1.83129558 |
| 120 | Impaired vibratory sensation (HP:0002495) | 1.82196803 |
| 121 | Gastroesophageal reflux (HP:0002020) | 1.81576450 |
| 122 | Vascular tortuosity (HP:0004948) | 1.81312232 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.79728305 |
| 124 | Thyroid carcinoma (HP:0002890) | 1.78723811 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.78495752 |
| 126 | Incomplete penetrance (HP:0003829) | 1.78455656 |
| 127 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78094790 |
| 128 | Absent/shortened dynein arms (HP:0200106) | 1.78094790 |
| 129 | Spinal cord lesions (HP:0100561) | 1.76500533 |
| 130 | Syringomyelia (HP:0003396) | 1.76500533 |
| 131 | Gait ataxia (HP:0002066) | 1.75948995 |
| 132 | Pulmonic stenosis (HP:0001642) | 1.75449751 |
| 133 | Abnormality of the frontal sinuses (HP:0002687) | 1.74433713 |
| 134 | Distal lower limb amyotrophy (HP:0008944) | 1.74311854 |
| 135 | Clumsiness (HP:0002312) | 1.74291486 |
| 136 | Type 2 muscle fiber atrophy (HP:0003554) | 1.71896923 |
| 137 | Intention tremor (HP:0002080) | 1.70837597 |
| 138 | Increased circulating renin level (HP:0000848) | 1.69419358 |
| 139 | Relative macrocephaly (HP:0004482) | 1.69353950 |
| 140 | Mild short stature (HP:0003502) | 1.68028076 |
| 141 | Bladder carcinoma (HP:0002862) | 1.67880207 |
| 142 | Bladder neoplasm (HP:0009725) | 1.67880207 |
| 143 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.67215865 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.64352690 |
| 145 | Macroorchidism (HP:0000053) | 1.63050646 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.63016000 |
| 147 | Memory impairment (HP:0002354) | 1.59519261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.72120761 |
| 2 | RIPK4 | 5.35499212 |
| 3 | NTRK3 | 4.98996473 |
| 4 | MAP3K4 | 2.66739160 |
| 5 | MAP3K9 | 2.66142568 |
| 6 | BMPR2 | 2.53707940 |
| 7 | MINK1 | 2.28989406 |
| 8 | CASK | 2.28861155 |
| 9 | PNCK | 2.21832568 |
| 10 | MAP2K7 | 2.21091690 |
| 11 | PLK2 | 2.18791099 |
| 12 | STK38L | 2.05162341 |
| 13 | IRAK3 | 2.01438678 |
| 14 | MAP3K12 | 1.90018854 |
| 15 | KSR2 | 1.88688514 |
| 16 | SIK2 | 1.86216811 |
| 17 | DAPK2 | 1.81598916 |
| 18 | KSR1 | 1.81005909 |
| 19 | MUSK | 1.75633208 |
| 20 | DAPK1 | 1.71244692 |
| 21 | NTRK1 | 1.69166762 |
| 22 | NME1 | 1.66439594 |
| 23 | MAP3K13 | 1.64902426 |
| 24 | PTK2B | 1.63725997 |
| 25 | MAP2K4 | 1.62678893 |
| 26 | STK24 | 1.60347649 |
| 27 | ARAF | 1.57337002 |
| 28 | MARK1 | 1.52134896 |
| 29 | FES | 1.50443909 |
| 30 | PAK6 | 1.49409149 |
| 31 | TNIK | 1.43212714 |
| 32 | CDK5 | 1.36952336 |
| 33 | CAMK2B | 1.36740800 |
| 34 | GRK5 | 1.34813561 |
| 35 | CAMK2A | 1.29655237 |
| 36 | FGR | 1.26826731 |
| 37 | RAF1 | 1.26060100 |
| 38 | PRPF4B | 1.21670461 |
| 39 | PRKCG | 1.18745902 |
| 40 | NEK6 | 1.15426146 |
| 41 | BRD4 | 1.15165131 |
| 42 | NTRK2 | 1.11196749 |
| 43 | CAMK1D | 1.03425681 |
| 44 | WNK1 | 1.01875147 |
| 45 | DDR2 | 1.01642158 |
| 46 | CAMKK1 | 1.00293089 |
| 47 | MAP3K2 | 0.90021346 |
| 48 | MAP3K5 | 0.89397717 |
| 49 | MAP3K14 | 0.88457303 |
| 50 | ERBB3 | 0.87982303 |
| 51 | RIPK1 | 0.86163830 |
| 52 | TAOK2 | 0.84838231 |
| 53 | STK38 | 0.84684432 |
| 54 | GRK7 | 0.83823591 |
| 55 | TRIM28 | 0.83175813 |
| 56 | SGK1 | 0.82831932 |
| 57 | PRKD3 | 0.82237916 |
| 58 | MAPK13 | 0.81753174 |
| 59 | FER | 0.80615553 |
| 60 | DYRK1A | 0.80098640 |
| 61 | IRAK2 | 0.78389039 |
| 62 | CAMK2D | 0.77920463 |
| 63 | DMPK | 0.76627701 |
| 64 | CCNB1 | 0.75660777 |
| 65 | PDGFRB | 0.75497857 |
| 66 | PDGFRA | 0.73196388 |
| 67 | PIK3CA | 0.72402045 |
| 68 | JAK1 | 0.69619046 |
| 69 | GRK6 | 0.68254941 |
| 70 | STK39 | 0.67175634 |
| 71 | PRKCE | 0.67136651 |
| 72 | CDK18 | 0.63732730 |
| 73 | ACVR1B | 0.63314869 |
| 74 | CAMKK2 | 0.63116804 |
| 75 | CDK14 | 0.62898329 |
| 76 | LATS1 | 0.61304697 |
| 77 | CDK15 | 0.59843128 |
| 78 | CAMK1 | 0.59042275 |
| 79 | AKT3 | 0.58857524 |
| 80 | MAP3K7 | 0.58445965 |
| 81 | MKNK2 | 0.58440516 |
| 82 | CAMK4 | 0.58225398 |
| 83 | MELK | 0.57577672 |
| 84 | PRKCQ | 0.56233364 |
| 85 | CDK19 | 0.55185570 |
| 86 | MAP2K1 | 0.54153650 |
| 87 | ALK | 0.53441899 |
| 88 | BRAF | 0.52015610 |
| 89 | TNK2 | 0.51356744 |
| 90 | TYRO3 | 0.51191003 |
| 91 | CDK11A | 0.50285340 |
| 92 | SGK223 | 0.49819574 |
| 93 | SGK494 | 0.49819574 |
| 94 | SGK2 | 0.49665457 |
| 95 | STK3 | 0.49241726 |
| 96 | STK11 | 0.49135116 |
| 97 | ROCK2 | 0.48699344 |
| 98 | PAK3 | 0.48291115 |
| 99 | MAP3K1 | 0.47458967 |
| 100 | PDPK1 | 0.46396842 |
| 101 | FYN | 0.46215327 |
| 102 | PRKCZ | 0.45571139 |
| 103 | RET | 0.44784974 |
| 104 | MARK2 | 0.44689919 |
| 105 | MAPK10 | 0.44591101 |
| 106 | SIK3 | 0.44340703 |
| 107 | OXSR1 | 0.42259891 |
| 108 | CAMK2G | 0.42170112 |
| 109 | PDK1 | 0.41766244 |
| 110 | MOS | 0.41591116 |
| 111 | MAPK7 | 0.40099112 |
| 112 | BCR | 0.38972820 |
| 113 | CAMK1G | 0.37143389 |
| 114 | UHMK1 | 0.35870525 |
| 115 | RPS6KA3 | 0.35224079 |
| 116 | PINK1 | 0.34872878 |
| 117 | MAP3K6 | 0.34762702 |
| 118 | CSNK1G2 | 0.32788746 |
| 119 | PRKCB | 0.31417879 |
| 120 | SYK | 0.30799868 |
| 121 | * PRKACA | 0.29934027 |
| 122 | * PRKCA | 0.29001488 |
| 123 | CSNK1E | 0.26820322 |
| 124 | SGK3 | 0.25985729 |
| 125 | MAPK12 | 0.24967487 |
| 126 | PRKG1 | 0.24777787 |
| 127 | LATS2 | 0.24769040 |
| 128 | PRKCH | 0.24132837 |
| 129 | PRKD2 | 0.21385186 |
| 130 | CSNK1A1 | 0.20329816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.44288391 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.34026839 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.01566481 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.91895689 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.86100828 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.79523737 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.60211234 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52678580 |
| 9 | * Salivary secretion_Homo sapiens_hsa04970 | 2.32298966 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.29757128 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28873939 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28493116 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 2.19675777 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.15145703 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 2.03168771 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.94336485 |
| 17 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.86465443 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.83511398 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.81640393 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81199753 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79590952 |
| 22 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77993821 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73254827 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49453797 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46889517 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46610490 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45169236 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43218397 |
| 29 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36119779 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.35652114 |
| 31 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31859257 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27783902 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27481911 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.21718070 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.20835584 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20754866 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20112034 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.19924252 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18700817 |
| 40 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.15051155 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14218780 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08384530 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08059653 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07741032 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06854523 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06603391 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.05633781 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.04723348 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03163074 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99286805 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98755349 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98694797 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94630571 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94538764 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93383554 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92512539 |
| 57 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.91184034 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89702147 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.88297513 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88031583 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87789952 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87393201 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84171138 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82783353 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82003839 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78564869 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78231057 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73684388 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.73477082 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73024628 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72901954 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.72013437 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71258737 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70591375 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70256687 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67845388 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67340914 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67150902 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66563446 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66421039 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66164382 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64568834 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63897908 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63895831 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62503607 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.61232394 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.60025437 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59998781 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59985998 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58200023 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57666094 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56718878 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.56287667 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.55701292 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.55345486 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54095191 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52988313 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50695649 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49830440 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48784040 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48731845 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46251373 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43446845 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38724260 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38670094 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38309993 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38221040 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37966470 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37744541 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37198497 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.34686107 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.33896758 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.33735659 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33001176 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32147667 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29540434 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29397576 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.28169134 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27905766 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27209725 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25810510 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.24703502 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.24375210 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23267284 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.21655869 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.21209182 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19917446 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.19217519 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19101272 |

